Literature DB >> 34724139

Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy.

Fabiana Gregucci1, Alba Fiorentino2, Rosario Mazzola3, Francesco Ricchetti3, Ilaria Bonaparte2, Alessia Surgo2, Vanessa Figlia3, Roberta Carbonara2, Morena Caliandro2, Maria Paola Ciliberti2, Ruggero Ruggieri3, Filippo Alongi3,4.   

Abstract

PURPOSE: Aim of this study is to assess the ability of contrast-enhanced CT image-based radiomic analysis to predict local response (LR) in a retrospective cohort of patients affected by pancreatic cancer and treated with stereotactic body radiation therapy (SBRT). Secondary aim is to evaluate progression free survival (PFS) and overall survival (OS) at long-term follow-up.
METHODS: Contrast-enhanced-CT images of 37 patients who underwent SBRT were analyzed. Two clinical variables (BED, CTV volume), 27 radiomic features were included. LR was used as the outcome variable to build the predictive model. The Kaplan-Meier method was used to evaluate PFS and OS.
RESULTS: Three variables were statistically correlated with the LR in the univariate analysis: Intensity Histogram (StdValue feature), Gray Level Cooccurrence Matrix (GLCM25_Correlation feature) and Neighbor Intensity Difference (NID25_Busyness feature). Multivariate model showed GLCM25_Correlation (P = 0.007) and NID25_Busyness (P = 0.03) as 2 independent predictive variables for LR. The odds ratio values of GLCM25_Correlation and NID25_Busyness were 0.07 (95%CI 0.01-0.49) and 8.10 (95%CI 1.20-54.40), respectively. The area under the curve for the multivariate logistic regressive model was 0.851 (95%CI 0.724-0.978). At a median follow-up of 30 months, median PFS was 7 months (95%CI 6-NA); median OS was 11 months (95%CI 10-22 months).
CONCLUSIONS: This analysis identified a radiomic signature that correlates with LR. To confirm these results, prospective studies could identify patient sub-groups with different rates of radiation dose-response to define a more personalized SBRT approach.
© 2021. Italian Society of Medical Radiology.

Entities:  

Keywords:  Local control; Pancreatic cancer; Predictive analysis; Radiomics; Stereotactic body radiation therapy

Mesh:

Substances:

Year:  2021        PMID: 34724139     DOI: 10.1007/s11547-021-01422-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  2 in total

1.  Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation.

Authors:  Valerio Nardone; Alfonso Reginelli; Fernando Scala; Salvatore Francesco Carbone; Maria Antonietta Mazzei; Lucio Sebaste; Tommaso Carfagno; Giuseppe Battaglia; Pierpaolo Pastina; Pierpaolo Correale; Paolo Tini; Gianluca Pellino; Salvatore Cappabianca; Luigi Pirtoli
Journal:  Gastroenterol Res Pract       Date:  2019-01-17       Impact factor: 2.260

2.  Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma.

Authors:  Luca Cozzi; Tiziana Comito; Antonella Fogliata; Ciro Franzese; Davide Franceschini; Cristiana Bonifacio; Angelo Tozzi; Lucia Di Brina; Elena Clerici; Stefano Tomatis; Giacomo Reggiori; Francesca Lobefalo; Antonella Stravato; Pietro Mancosu; Alessandro Zerbi; Martina Sollini; Margarita Kirienko; Arturo Chiti; Marta Scorsetti
Journal:  PLoS One       Date:  2019-01-18       Impact factor: 3.240

  2 in total
  3 in total

1.  Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.

Authors:  Giuditta Chiti; Giulia Grazzini; Federica Flammia; Benedetta Matteuzzi; Paolo Tortoli; Silvia Bettarini; Elisa Pasqualini; Vincenza Granata; Simone Busoni; Luca Messserini; Silvia Pradella; Daniela Massi; Vittorio Miele
Journal:  Radiol Med       Date:  2022-08-02       Impact factor: 6.313

2.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

3.  Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy.

Authors:  Osamu Tanaka; Takuya Taniguchi; Kousei Adachi; Shuto Nakaya; Takuji Kiryu; Akira Ukai; Chiyoko Makita; Masayuki Matsuo
Journal:  Radiat Oncol       Date:  2022-07-31       Impact factor: 4.309

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.